Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.2251
-0.0067 (-2.89%)
Oct 26, 2026, 10:01 AM EDT - Market open
Mangoceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.23 | 1.49 | 0.06 | 0.74 | 0.68 | 0.02 |
Cash & Short-Term Investments | 0.23 | 1.49 | 0.06 | 0.74 | 0.68 | 0.02 |
Cash Growth | 126.38% | 2434.12% | -92.06% | 8.22% | 2928.20% | - |
Inventory | - | - | - | 0.02 | - | - |
Prepaid Expenses | 0 | 0.01 | - | - | 0.01 | - |
Other Current Assets | 0.02 | 0.05 | 0.02 | 0.08 | - | - |
Total Current Assets | 0.25 | 1.55 | 0.08 | 0.84 | 0.69 | 0.02 |
Property, Plant & Equipment | 0.28 | 0.31 | 0.18 | 0.22 | 0.29 | - |
Other Intangible Assets | 13.65 | 14.23 | 15.23 | - | - | - |
Other Long-Term Assets | - | - | -0.12 | - | 0.02 | - |
Total Assets | 14.17 | 16.09 | 15.37 | 1.05 | 1 | 0.02 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.93 | 0.42 | 0.84 | 0.14 | 0.03 | - |
Accrued Expenses | 0.01 | 0.01 | - | 0.01 | 0 | - |
Short-Term Debt | - | - | 0.15 | - | 0.17 | 0.04 |
Current Portion of Leases | 0.03 | 0.31 | 0.06 | 0.06 | 0.06 | - |
Other Current Liabilities | 0.15 | 0.16 | 0.37 | - | - | - |
Total Current Liabilities | 1.4 | 0.89 | 1.43 | 0.21 | 0.26 | 0.04 |
Long-Term Leases | 0.25 | - | - | 0.06 | 0.13 | - |
Total Liabilities | 1.65 | 0.89 | 1.43 | 0.28 | 0.39 | 0.04 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Additional Paid-In Capital | 57.57 | 55.52 | 34.79 | 12 | 2.63 | 0 |
Retained Earnings | -45.36 | -40.65 | -20 | -11.23 | -2.02 | -0.02 |
Comprehensive Income & Other | 0.32 | 0.32 | -0.84 | - | - | - |
Total Common Equity | 12.53 | 15.2 | 13.95 | 0.77 | 0.61 | -0.02 |
Minority Interest | -0 | -0 | -0 | - | - | - |
Shareholders' Equity | 12.52 | 15.2 | 13.95 | 0.77 | 0.61 | -0.02 |
Total Liabilities & Equity | 14.17 | 16.09 | 15.37 | 1.05 | 1 | 0.02 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 0.28 | 0.31 | 0.21 | 0.13 | 0.35 | 0.04 |
Net Cash (Debt) | -0.05 | 1.18 | -0.16 | 0.61 | 0.33 | -0.02 |
Net Cash Growth | - | - | - | 84.95% | - | - |
Net Cash Per Share | -0.00 | 0.12 | -0.08 | 0.57 | 0.46 | -0.03 |
Filing Date Shares Outstanding | 21.57 | 16.97 | 5.17 | 1.53 | 0.89 | 0.53 |
Total Common Shares Outstanding | 18.02 | 15.89 | 3.25 | 1.43 | 0.89 | 0.53 |
Working Capital | -1.15 | 0.66 | -1.35 | 0.62 | 0.43 | -0.02 |
Book Value Per Share | 0.70 | 0.96 | 4.30 | 0.54 | 0.69 | -0.03 |
Tangible Book Value | -1.12 | 0.97 | -1.29 | 0.77 | 0.61 | -0.02 |
Tangible Book Value Per Share | -0.06 | 0.06 | -0.40 | 0.54 | 0.69 | -0.03 |
Machinery | - | 0.01 | 0.12 | 0.12 | 0.12 | - |